Accessibility Menu
BlackRock Health Sciences Trust logo

BlackRock Health Sciences Trust(NYSE) BME

Market Cap$592.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+927%
5 Year+31%
1 Year+34%
1 Month+6%
$45.81
-0.43%
-0.20Today
BlackRock Health Sciences Trust last closing stock price
MetricPriceDate
Last closeUSD 45.812026-09-04
BlackRock Health Sciences Trust stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.15%USD 45.882026-08-28
1 month+6.06%USD 43.192026-08-05
3 month+16.84%USD 39.212026-06-05
Year to date+17.18%USD 39.092025-12-31
1 year+34.3%USD 34.112025-09-04
3 year+43.38%USD 31.952023-09-05
5 year+31.17%USD 34.922021-09-03
Since inception+926.71%USD 4.462005-03-29

BlackRock Health Sciences Trust Financials at a Glance

Market Cap

$592.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$63.04M

Net Income (TTM)

$100.42M

EPS (TTM)

$8.05

P/E Ratio

5.69

Dividend

$3.15

Beta (Volatility)

0.48 (Low)

Price

$45.81

Volume

35,255.225

Open

$45.63

Previous Close

$45.81

Daily Range

$45.50 - $45.97

52-Week Range

$35.95 - $46.43

Estimated Earnings Date

N/A

BME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund managed by BlackRock, Inc. The fund focuses on investing in companies within the health sciences sector, including pharmaceuticals, biotechnology, and medical devices.

Products and Services
  • Invests in public equity markets of the United States
  • Focuses on health sciences and related sectors
  • Utilizes equity derivatives with an emphasis on option writing
Growth Outlook
  • Recent quarterly revenue reached $22.8 million, showing strong performance
  • Trailing twelve months (TTM) revenue of $66.5 million indicates growth potential
  • Net income for the latest quarter was $8.05 million, reflecting profitability
Financial Highlights
  • Dividend yield of 7.08% offers attractive income potential
  • Price-to-earnings (P/E) ratio of 7.46 suggests undervaluation compared to peers
  • Market capitalization stands at approximately $573.8 million, indicating solid market presence
BlackRock Health Sciences Trust aims to capitalize on the growing demand for health-related investments. The fund's focus on the health sciences sector positions it well to benefit from advancements in medical technology and pharmaceuticals. Recent financial performance highlights a robust revenue stream and profitability, making it an appealing option for investors interested in the health sector. The attractive dividend yield and favorable valuation metrics further enhance its investment appeal.
AI Generated • Aug 19, 2026

Industry

Capital Markets

Sector

Financials

CEO

John M. Perlowski, CPA

Headquarters

New York, NY 10001, US

BME Financials

Key Financial Metrics (TTM)

Gross Margin

89.28%

Operating Margin

305.20%

Net Income Margin

288.16%

Return on Equity

14.30%

Return on Capital

13.53%

Return on Assets

13.50%

Earnings Yield

17.57%

Dividend Yield

6.87%

Payout Ratio

52.76%

Stock Overview

Market Cap

$592.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.92M

Volume

35.26K

Avg. Volume

45.40K

Financials (TTM)

Gross Profit

$53.82M

Operating Income

$105.02M

EBITDA

$105.03M

Operating Cash Flow

$19.12M

Capital Expenditure

-$3.00

Free Cash Flow

$19.12M

Cash & ST Invst.

$4.92M

Total Debt

$894.33K

BlackRock Health Sciences Trust Performance Analysis

BlackRock Health Sciences Trust annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 21,403,690-59.8%
20232023-12-31USD 34,895,72563.0%
20242024-12-31USD 36,328,2794.1%
20252025-12-31USD 36,159,448-0.5%
BlackRock Health Sciences Trust sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-102.1%
Q42024-12-319664.0%
Q22025-06-30-89.2%
Q42025-12-31475.0%
BlackRock Health Sciences Trust annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.91N/A
20232023-12-31USD 1.44N/A
20242024-12-31USD 1.7723.3%
20252025-12-31USD 5.92234.6%
BlackRock Health Sciences Trust sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30432.3%
Q42024-12-31-151.5%
Q22025-06-3083.5%
Q42025-12-312325.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$22.75M

+24.4%

Gross Profit

$19.89M

+30.2%

Gross Margin

87.41%

N/A

Market Cap

$592.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$80.53M

+824.9%

EBITDA

$80.55M

+824.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$4.92M

+920439.5%

Total Debt

$894.33K

+1373.7%

Accounts Receivable

$428.14K

-72.8%

Inventory

$0.00

N/A

Long Term Debt

$894.33K

+1373.7%

Short Term Debt

$0.00

-100.0%

Return on Assets

13.50%

N/A

Return on Invested Capital

14.30%

N/A

Free Cash Flow

-$9.45M

-440.1%

Operating Cash Flow

-$9.45M

-440.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BHKBlackRock Core Bond Trust
$8.94-0.22%
BGYBlackRock Enhanced International Dividend Trust
$5.91+0.00%
DPGDuff & Phelps Utility and Infrastructure Fund Inc.
$14.13-0.56%
BLEBlackRock Municipal Income Trust II
$10.54-0.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About BME

What is the current price of BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust is trading at $45.81 per share.

What is the 52-week range for BlackRock Health Sciences Trust?

Over the past 52 weeks, BlackRock Health Sciences Trust has traded between $35.95 and $46.43.

How much debt does BlackRock Health Sciences Trust have?

As of the most recent reporting period, BlackRock Health Sciences Trust reported total debt of $894.33K.

How much cash does BlackRock Health Sciences Trust have on hand?

BlackRock Health Sciences Trust reported $548.00 in cash and cash equivalents in its most recent financial results.

What is BlackRock Health Sciences Trust’s dividend yield?

BlackRock Health Sciences Trust currently has a dividend yield of 6.87%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services